* Benson: Tuition increases will help preserve CU's quality, competitive edge
   
* Self-funded health plan study continues
   
* ISIS takes on student registration
   
* Details of state budget command focus at the Capitol
   
* 5 questions for Kathie Novak
   
* Conference on World Affairs opens Monday
   
* President's Teaching and Learning Collaborative extends deadline for proposals
   
* People
   
* Did you know...
   
* Letters to the editor
 
 NEWS FROM THE CU SYSTEM
 
  CU-BOULDER
  New PLI director Steve Grace hits ground running
 
  UCCS
  3OH!3 to headline concert on campus
 
  UC DENVER
  Auraria Campus to host Safe Campus Night
 
  ANSCHUTZ MEDICAL CAMPUS
  Hospital receives distinguished designation for excellence in nursing
 
  TECH TRANSFER
  CU cardiovascular monitoring technology to be commercialized
 
 
   Home
   Newsletter Archive
 
 
 
 
 
 
 
 
 
 
 
Download Newsleter in PDF
 
Share your thoughts
  LETTERS TO THE EDITOR
Share your opinions

CONTACT US
Send your thoughts and suggestions for the Newsletter
   

News from the CU system - Tech Transfer

CU cardiovascular monitoring technology to be commercialized

The University of Colorado recently completed a license agreement with Flashback Technologies LLC for CU technology enabling fast, noninvasive detection of acute blood loss volume and prediction of cardiovascular collapse in emergency situations.

Hemorrhagic shock — physical shock caused by rapid blood loss — is a leading cause of death on the battlefield and in civilian trauma settings. Flashback's first product, CipherSensor, analyzes real-time physiological data such as blood oxygen level and blood pressure to detect subtle hemodynamic changes in real-time. CipherSensor's algorithms quickly and accurately detect the early onset of blood loss, continuously estimate blood loss volume, and predict a patient's individual risk for cardiovascular collapse. The technology will enable medical professionals to quickly identify bleeding patients and triage them to an appropriate trauma center.

"The predictive power of Flashback's technology represents a gigantic leap forward in physicians' ability to use continuous, real-time vital sign data to direct the diagnosis and treatment of human disease and traumatic injury," said Paul Tabor of the CU Technology Transfer Office. "We are eager to see how this technology is further developed for use in numerous clinical settings."

The algorithms used in CipherSensor were developed by Steven Moulton, M.D., a professor in the surgery department at the University of Colorado School of Medicine with a joint appointment at The Children's Hospital, and Greg Grudic, formerly an assistant professor in the CU-Boulder computer science department and now chief technology officer at Flashback. Moulton and Grudic believe their platform technology can be applied to a wide range of medical conditions, including intracranial hypertension, seizure monitoring, childhood asthma, congestive heart failure and anesthesia monitoring.

"CipherSensor uses advanced mathematics and machine learning techniques to discover and model previously hidden physiological relationships," Grudic said.

Added Moulton, "Our algorithms analyze streaming vital sign data, looking for beat-to-beat changes that no human could detect. CipherSensor represents an entirely new type of intelligent, predictive medical device."

Further development work is in progress at Flashback, the University of Colorado and the U.S. Army Institute of Surgical Research under a Cooperative Research and Development Agreement with the U.S. Army.

Bookmark - Print - Share

 
Previous Tech Transfer Stories

03/10/2010
Israel-based company licenses water desalination technology

03/03/2010
Colorado company licenses CU test to assess chronic liver disease

01/20/2010
AgriHouse completes license for CU water management technology

01/13/2010
AmideBio licenses technology from CU

01/06/2009
Business collaboration leads to high ranking for CU-Boulder

12/16/2009
License agreement gives Viral Genetics Inc. right to develop cancer therapies

12/09/2009
Soligenix options CU vaccine technology

12/02/2009
Aurora company licenses CU technology for 3-D heart modeling

09/23/2009
Colorado firm aims to commercialize CU breakthroughs in pain management

09/16/2009
Office reports best year for invention disclosures

09/16/2009
Office invites bioscience faculty to submit grant proposals

09/02/2009
Reading software based on CU technology draws national attention

08/19/2009
CU startup to develop 'biogenerator' for medical devices

08/06/2009
CU startup licenses social networking iPhone app